Monitoring Life at S4i – Science for Industry 2025

Introduction

Innovation in healthcare doesn’t happen in isolation—it grows through collaboration, visibility, and continuous progress.

For the second year in a row, Monitoring Life participated in S4i | Science for Industry at the Fundación Parque Científico de Madrid, sharing its evolution, mission, and the tangible progress being made in heart failure monitoring.

What makes this year different is simple: traction, validation, and real clinical impact.

1.From Early Stage to Real Progress

Last year, Monitoring Life entered S4i at an early stage—just beginning clinical trials and validating its technology.

Fast forward to today:

• Collaboration with 8 hospitals across Spain

• Ongoing clinical validation in real environments

• Active progress through the regulatory pathway

This shift marks a key transition—from concept to execution.

👉 The focus is no longer just innovation, but implementation and scale.

2.Representing Growth and Vision

This year, the company was represented by:

• Sarai Paz Fernández

• Esmeralda Zefi

Their presence reflected both operational maturity and a clear communication of the company’s vision: transforming cardiac care through remote monitoring and data-driven insights.

3.The Value of S4i: Beyond Visibility

Events like S4i are not just about showcasing technology—they are about connecting with the ecosystem that drives innovation forward.

For Monitoring Life, this means:

• Engaging with deep-tech companies

• Sharing knowledge and challenges

• Exploring future collaborations

In a space where healthcare, AI, and engineering converge, these interactions accelerate progress.

Conclusion

Returning to S4i for a second year is more than a milestone—it’s proof of momentum.

The journey from early trials to real clinical partnerships highlights a clear trajectory: building solutions that move beyond theory and into real-world impact.

Because the future of healthcare isn’t just about innovation.

It’s about execution.